Chiron Begins Fluvirin Manufacturing After U.K. Clears Site
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.K. Medicines & Healthcare products Regulatory Agency lifts its suspension of Chiron's license to manufacture Fluvirin at its Liverpool facility. FDA says it will inspect the facility once "all the critical stages of manufacturing are in full swing."